Skip to main content

Market access for medical technologies in Greece

A brief overview of key market access pathways and challenges for medical devices, in-vitro diagnostic tests in Greece


Key topics

There is only one key theme describing market access for medical technologies in Greece: 

  • Reimbursement: payment mechanism via the DRG system, separately paid devices


In January 2024, the Greek DRG system replaced the old KEN-DRG system in reimbursing hospital care in Greece. The current system is based on the German DRG system. 

DRGs are determined by the combination of a procedure code (Greek Medical Procedure Classification) and a diagnosis code (ICD-10-GrM). The procedure coding classification and the DRG system are maintained by the Greek DRG Institute (ΚΕ.ΤΕ.Κ.Ν.Υ.). As the system has only been introduced recently, the possibilities to implement changes in the procedural classification or the DRG system are still not well defined. 

Certain high cost devices and procedures can be paid for separately, outside of the DRG system. These technologies and procedures can be found in the Integrated Regulation for Health Services (EKPY), maintained by the National Organization for the Provision of Health Services (EOPYY).


Specifics for IVD tests

In-vitro diagnostic tests provided in ambulatory settings are reimbursed on a fee-for-service basis via the EOPYY List of medical procedures, maintained by EOPYY.

Get in touch

Contact us to discuss your needs and learn about our services